Skip to main content

Summary

for females ages 18 years and up (full criteria)
at San Francisco, California and other locations
study started
estimated completion:

Description

Summary

The purpose of this study is to study patients presenting with stage IV breast cancer. Stage IV means that the breast cancer has spread to another part of the body outside the breast. This study is important because in different parts of the country some patients are being offered surgical treatment for the breast tumor and some are not. The doctors do not know if surgery for the breast tumor is helpful in patients with stage IV breast cancer. The doctors will collect information about the patient and their treatment to learn more about how patients and doctors make treatment decisions. The doctor will also collect blood samples and tissue samples for laboratory studies to learn more about tumors that have spread to other parts of the body.

Official Title

A Prospective Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer

Keywords

Breast Cancer Breast Blood and tissue collection Epidemiologic Questionnaire TBCRC (Translational Breast Cancer Research Consortium) 09-056 Breast Neoplasms

Eligibility

You can join if…

Open to females ages 18 years and up

  • Age 18 years or older
  • Known or suspected Stage IV breast cancer with intact primary tumor
  • Known or suspected Stage IV breast cancer with intact primary tumor, having begun systemic therapy within the past 12 months
  • Known or suspected Stage IV breast cancer within 3 months of local breast surgery
  • Known or suspected Stage IV breast cancer within 3 months of local breast surgery,having begun systemic therapy within the past 12 months

You CAN'T join if...

  • Primary breast cancer diagnosis made by FNA only and no pre-treatment core biopsy planned for diagnostic or research purposes.
  • Failure of MSKCC or participating site to confirm Stage IV breast cancer diagnosis by biopsy within 30 days of study enrollment

Locations

  • University of California San Francisco
    San Francisco, California, 94143, United States
  • Md Anderson Cancer Center
    Houston, Texas, 77030, United States
  • Mayo Clinic
    Rochester, Minnesota, 55905, United States
  • University of Chicago
    Chicago, Illinois, United States
  • Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee, 37232, United States
  • The Indiana University Simon Cancer Center
    Indianapolis, Indiana, United States
  • University of Alabama at Birmingham
    Birmingham, Alabama, 35294, United States
  • University of Michigan Health System
    Ann Arbor, Michigan, 48109, United States
  • University of Pittsburgh Medical Center
    Pittsburgh, Pennsylvania, United States
  • University of North Carolina School of Medicine
    Chapel Hill, North Carolina, 27514, United States
  • Duke University
    Durham, North Carolina, United States
  • Georgetown University
    Washington, D.C., District of Columbia, United States
  • Washington Cancer Institute at Washington
    Washington, D.C., District of Columbia, United States
  • John Hopkins Medical Center
    Baltimore, Maryland, 21287, United States
  • Memoral Sloan Kettering Cancer Center
    Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center
    New York, New York, 10065, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk
    Commack, New York, 11725, United States
  • Dana Farber Cancer Institute
    Boston, Massachusetts, 02115, United States

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Memorial Sloan Kettering Cancer Center
Links
Memorial Sloan Kettering Cancer Center
ID
NCT00941759
Lead Scientist
Michael Alvarado
Study Type
Observational
Last Updated
September 6, 2017